Vydura (Rimegepant) 75mg Oro-Lyophilisate
£56.99
VYDURA is used to treat and prevent migraine attacks in adults who have already been diagnosed with migraine, following a clinical assessment.
It contains rimegepant, which works by blocking CGRP (calcitonin gene-related peptide). This helps stop an active migraine attack and can reduce the number of migraine attacks when taken preventively.
Please Note: You are also required to complete a form at checkout. In addition, a video consultation with our pharmacist may be required.
Out of stock
This product is currently out of stock.
Categories: General, Migraine, Online Clinic
Tags: Private Rx
What is VYDURA?
VYDURA is used to treat acute migraine attacks with or without aura in adults who have already been diagnosed with migraine. It is also used as a preventive treatment for adults with episodic migraine who experience at least 4 migraine attacks per month.
How VYDURA works
VYDURA contains rimegepant, which targets calcitonin gene-related peptide (CGRP), a substance that may be elevated in people with migraine. Rimegepant blocks CGRP from attaching to its receptor, which helps to:
- Stop an active migraine attack.
- Reduce the frequency of migraine attacks when taken preventively.
By targeting CGRP, VYDURA helps manage both the symptoms and recurrence of migraine attacks.
Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure how to use this medicine.
The recommended dose for acute treatment of migraines in adults:
One tablet, as needed, once a day
The recommended dose for prophylaxis of migraines in adults:
One tablet, taken every other day
VYDURA is for oral use. The oral lyophilisate can be taken with or without food or water.
If you take more VYDURA than you should
Talk to your doctor or pharmacist or go to a hospital straight away. Take the medicine pack and this leaflet with you.
If you forget to take VYDURA
If you take VYDURA for the prevention of migraine and you miss a dose, just take the next dose at the usual time. Do not take a double dose to make up for a forgotten dose.
Like all medicines, this medicine can cause side effects, although not everybody gets them. Some of the side effects are temporary with continued treatment or disappeared when treatment is stopped.
Side Effects
Common
- Nausea
Serious Side Effects
Stop using VYDURA and contact your doctor straight away if you have signs of an allergic reaction (such as severe rash or shortness of breath) or signs of a severe allergic reaction known as ‘anaphylaxis’ (such as swelling of tongue, mouth or face, trouble swallowing or breathing, throat tightness, or hoarseness).
Allergic reactions, including anaphylaxis, with VYDURA are uncommon.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme, website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.
Warning & Precautions
Do not take VYDURA
- if you are allergic to rimegepant or any of the other ingredients of this medicine
Talk to your doctor or pharmacist before taking VYDURA, if any of the following applies to you:
- if you have severe liver problems
- if you have reduced kidney function or are on kidney dialysis
During treatment with VYDURA, stop taking this medicine and tell your doctor immediately:
- if you experience any symptoms of an allergic reaction (e.g., trouble breathing, severe rash, swelling of tongue, mouth or face, trouble swallowing, throat tightness, or hoarseness). These symptoms can occur several days after administration.
Age Restrictions
For adults over the age of 18 years
Other Medicines and Conditions
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This is because some medicines may affect the way VYDURA works or VYDURA may affect how other medicines work.
The following is a list of examples of medicines that should be avoided when taking VYDURA:
- itraconazole and clarithromycin
- ritonavir and efavirenz (medicines to treat HIV infections)
- bosentan
- St. John’s wort
- phenobarbital
- rifampicin
- modafinil
Do not take VYDURA more than once every 48 hours with:
- fluconazole and erythromycin (medicines used to treat fungal or bacterial infections).
- diltiazem, quinidine, and verapamil (medicines used to treat an abnormal heart rhythm, chest pain (angina) or high blood pressure).
- cyclosporin (a medicine used to prevent organ rejection after an organ transplant).
Pregnancy and Breastfeeding
Not recommended for use in pregnancy and breastfeeding.
Patient Information Leaflet
https://www.medicines.org.uk/emc/files/pil.13928.pdf
Ingredients
- Active Ingredients: Rimegepant
- Other Ingredients: gelatine, mannitol, mint flavour, and sucralose
Product Information
- Brand Name: Vydura
- Route of Administration: Oral
- Legal Classification: POM
- Strength: 75mg
- Dosage Form: Oral lyophilisate
Storage
- Keep this medicine out of the sight and reach of children.
- Do not use this medicine after the expiry date which is stated on the carton and the blister after EXP.
- The expiry date refers to the last day of that month.
- Do not store above 30 °C. Store in the original blister in order to protect from moisture.
- Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Advice and Helpful Links
